Approaches in the safety evaluations of veterinary antimicrobial agents in food to determine the effects on the human intestinal microflora

Journal of Veterinary Pharmacology and Therapeutics

Volumn 28, Issue 1, 2005, Pages 3-20

  Cerniglia, Carl E ^a   Kotarski, S ^b  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^b ZOETIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL DERIVATIVE; COUMARIN DERIVATIVE; CYCLOPEPTIDE; DITERPENE; DRUG RESIDUE; FOOD ADDITIVE; LINCOSAMIDE; MACROLIDE; PENICILLIN DERIVATIVE; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE DERIVATIVE; VETERINARY DRUG;

ACCEPTABLE DAILY INTAKE; ANALYTIC METHOD; ANTIBIOTIC RESISTANCE; AUSTRALIA; BACTERIAL COLONIZATION; DRUG EXPOSURE; DRUG PROGRAM; DRUG SAFETY; DRUG SCREENING; EUROPE; FOOD CHAIN; FOOD INTAKE; FOOD SAFETY; GOVERNMENT REGULATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INTERNATIONAL COOPERATION; INTESTINE FLORA; LIVESTOCK; MAXIMUM ALLOWABLE CONCENTRATION; MAXIMUM RESIDUE LEVEL; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; REGISTRATION; REVIEW; RISK ASSESSMENT; STANDARDIZATION; UNITED STATES;

ANIMALS; ANTI-BACTERIAL AGENTS; CONSUMER PRODUCT SAFETY; DECISION TREES; DRUG RESIDUES; GUIDELINES; HUMANS; INTESTINES; LEGISLATION, FOOD; MICROBIAL SENSITIVITY TESTS; UNITED STATES; VETERINARY DRUGS;

ANIMALIA;

EID: 14844362553     PISSN: 01407783     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2004.00595.x     Document Type: Review

References (56)

1. Australia National Registration Authority (2000) Veterinary Requirement Series. Part 10. Special Data Requirements. Submission to the Working Party on Antibiotics in Support of the Approval of New Antibiotic Active Constituents and Registration of Veterinary Chemical Products containing Antibiotic Active Constituents, and Significant Variations to such Products (new Dosage Forms, Extensions to Use). Available at: http://www.apvma.gov.au/guidelines/ vetguideline10.pdf.
2. Carman, R.J., Van Tassell, M.S. & Wilkins, T.D. (1993) The normal intestinal microflora: ecology, variability and stability. Veterinary and Human Toxicology, 35 (Suppl. 1), 11-14.
3. Cerniglia, C.E. & Kotarski, S. (1999) Evaluation of veterinary drug residues in food for their potential to affect human intestinal microflora. Journal of Regulatory Toxicology and Pharmacology, 29, 238-261.
4. Chadwick, R.W., George, S.E. & Claxton, L.R. (1992) Role of gastrointestinal mucosa and microflora in the bioactivation of dietary and environmental mutagens or carcinogens. Drug Metabolism Reviews. 24, 425-492.
5. Concordet, D. & Toutain, P.L. (1997a) The withdrawal time estimation of veterinary drugs: a non-parametric approach. Journal of Veterinary Pharmacology and Therapeutics. 20, 374-379.
6. Concordet, D. & Toutain, P.L. (1997b) The withdrawal time estimation of veterinary drug revisited, Journal of Veterinary Pharmacology and Therapeutics, 20, 380-386.
7. Corpet, D.E. (1992) Current status of models for testing antibiotic residues. Veterinary Human Toxicology. 35 (Suppl. 1), 37-46.
8. Corpet, D.E. (1993a) An evaluation of methods to assess the effect of antimicrobial residues on the human gut flora. Veterinary Microbiology, 35, 199-212,
9. Corpet, D.E. (1993b) Current status of model for testing antibiotic residues, Veterinary and Human Toxicology. 35 (Suppl, 1), 37-46.
10. Cummings, J.H., Banwell, J.G., Segal, I., Coleman, N., Englyst, H.N. & MacFarlane, G.T. (1990) The amount and composition of large bowel contents in man. Gastroenterology. 98, A408.
11. Drasar, B.S. & Duerden, B.I. (1991) Anaerobes in the normal flora of man. In Anaerobes in Human Disease. Eds Duerden, B.I. & Drasar, B.S. pp. 162-179, Wiley-Liss. New York, NY. USA.
12. Edlund, C. & Nord, C.E. (1999) Effect of quinolones on intestinal ecology. Drugs. 58 (Suppl. 2), 65-70.
13. EMEA CVMP (1994) Safety Evaluation of Antimicrobial Substances Regarding the Effects on Human Gut Flora. Committee for Veterinary Medicinal Products Working Party on the Safety of Residues. Brussels, Belgium (Guideline Document No. III/5619/94-EN).
14. EMEA CVMP (1995) Note for Guidance: Approach Towards Harmonization of Withdrawal Periods. EMEA/CVMP/036/95-Final.
15. EMEA CVMP (2001) Background Paper to the Revision of the CVMP Guideline on Safety Evaluation of Antimicrobial Substances Regarding the Effects on Human Gut Flora. EMEA/CVMP/235/01-FINAL. Available at: http://www.emea.eu.int/index/ indexv1.htm.
16. EMEA CVMP (2002a) Revised Guideline on Safety Evaluation of Antimicrobial Substances Regarding the Effects on Human Gut Flora. EMEA/CVMP/234/01-FINAL. Available at: http://www.emea.eu.int/index/indexv1.htm.
17. EMEA CVMP (2002b) Guideline on Pre-authorization Studies to Assess the Potential for Resistance Resulting from the Use of Antimicrobial Veterinary Medicinal Products. Guideline Document No. EMEA/CVMP/244/01-FINAL-corr. Available at: http://www.emea.eu.int/index/indexv1.htm.
18. European Council (1986) Residues of Veterinary for Drugs in Food of Animal Origin. Directive EC 86/496.
19. FAO/WHO (1988) Evaluation of Certain Veterinary Drug Residues in Food. Thirty-second Meeting of the Joint FAO/WHO Expert Committee on Food Additives. (WHO Food Additives Series 763).
20. FAO/WHO (1990) Evaluation of Certain Veterinary Drug Residues in Food. Thirty-sixth Meeting of the Joint FAO/WHO Expert Committee on Food Additives. (WHO Food Additives Series 799).
21. FAO/WHO (1991) Evaluation of Certain Veterinary Drug Residues in Food. Thirty-eighth Meeting of the Joint FAO/WHO Expert Committee on Food Additives. (WHO Food Additives Series 815).
22. FAO/WHO (1994) Evaluation of Certain Veterinary Drug Residues in Food. Forty-second Meeting of the Joint FAO/WHO Expert Committee on Food Additives. (WHO Food Additives Series 33).
23. FAO/WHO (1995) Evaluation of Certain Veterinary Drug Residues in Food. Forty-fifth Meeting of the Joint FAO/WHO Expert Committee on Food Additives. (WHO Food Additives Series 34).
24. FAO/WHO (1996) Evaluation of Certain Veterinary Drug Residues in Food, forty-seventh Meeting of the Joint FAO/WHO Expert Committee on Food Additives. (WHO Food Additives Series 36).
25. FAO/WHO (1997) Evaluation of Certain Veterinary Drug Residues in Food. Forty-seventh Meeting of the Joint FAO/WHO Expert Committee, on Food Additives. (WHO Food Additives Series 33).
26. FAO/WHO (1998) Evaluation of Certain Veterinary Drug Residues in Food. Fiftieth Meeting of the Joint FAO/WHO Expert Committee on Food Additives. (WHO Food Additives Series 38).
27. FAO/WHO (2000) Evaluation of Certain Veterinary Drug Residues in Food. Fifty-second Meeting of the Joint FAO/WHO Expert Committee on Food Additives. (WHO Food Additives Series 39).
28. FAO/WHO (2002) Evaluation of Certain Veterinary Drug Residues in Food, Fifty-eighth Meeting of the Joint FAO/WHO Expert Committee on Food Additives. (WHO Food Additives Series 43).
29. Finegold, S.M., Mathisen, G.E. & George, W.L. (1983) Changes in human intestinal flora related to the administration of antimicrobial agents. In Human intestinal Microflora in Health and Disease. Ed, Hentges. D.J. pp. 355-429. Academic Press. Inc., New York, USA.
30. Fisch, R.D. (2000) Withdrawal time estimation of veterinary drugs: extending the range of statistical methods. Journal of Veterinary Pharmacology and Therapeutics, 23, 159-162,
31. Fitzpatrick, S.C. (1995) New approaches to toxicological testing of residues-defining the 'residue of toxicological concern'. Drug Metabolism Reviews, 27, v-vi.
32. Freischem, B.J. (2000) Regulation of residues of antimicrobial veterinary medicinal products in food in the European Union. Microbial Ecology in Health and Disease, (Suppl. 1), 1-5.
33. Friedlander, L.G., Brynes, S.D. & Fernandez, A.H. (1999) The human food safety evaluation of new animal drugs. Veterinary Clinics of North America Food Animal Practice, 15, 1-11.
34. Gorbach, S.L. (1993) Perturbation of intestinal microflora. Veterinary and Human Toxicology, 35 (Suppl. 1), 15-23.
35. Heimdahl, A., Kager, L. & Nord, C.E. (1985) Changes in the oropharyngeal and colon microflora in relation to antimicrobial concentrations in saliva and feces. Scandinavian Journal of infectious Diseases. 44, 52-58.
36. Inter-Agency Coordinating Committee on the Validation of Alternative Methods (ICCVAM) (1997) Validation and Regulatory Acceptance of Toxicological Test Methods. National Institutes of Health. Publication No. 97-3981.
37. McConville, M.L., Dijkstra, J.W., Stamm, J.M., Van Saene, J.J.M. & Nouws, J.F.M. (1995) Effects of sarafloxacin hydrochloride on human enteric bacteria under simulated human gut conditions. The Veterinary Quarterly. 17, 1-5.
38. Martinez, M., Friedlander, L., Condon, R., Meneses, J., O'Rangers, J., Weber, N. & Miller, M. (2000) Response to criticisms of the US FDA parametric approach for withdrawal time estimation: rebuttal and comparison to the non-arametric method proposed by Concordet and Toutain. Journal of Veterinary Pharmacology and Therapeutics. 23, 21-35.
39. Moore, W.E. & Holdeman, L.V. (1974) Human fecal flora: the normal flora of 20 Japanese-Hawaiians. Applied Microbiology, 27, 961-979.
40. Moore, W.E.C. & Moore, L.H. (1995) Intestinal floras of populations that have a high risk of colon cancer. Applied and Environmental Microbiology, 61, 3202-3207.
41. National Committee for Clinical Laboratory Standards (2002) Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals. Approved Standard. M31-A2 NCCLS. Villanova. PA. 86 pp.
42. National Committee for Clinical Laboratory Standards (2003) Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria, M11-A5. Approved Standard. NCCLS. Villanova. PA. 36 pp.
43. Nouws, J.F.M., Kuiper, H., Van Klingeren, B. & Kruyswijk, P.G. (1994) Establishment of a microbiologically acceptable daily intake of antimicrobial drug residues. Veterinary Quarterly. 16, 152-156.
44. Rollins, L.D., Gaines, S.A., Pocurull, D.W. & Mercer, H.D. (1975) Animal model for determining the no-effect level of an antimicrobial drug on drug resistance in the lactose-fermenting enteric flora. Antimicrobial Agents and Chemotherapy. 7, 661-665.
45. Rumney, C.J. & Rowland, I.R. (1992) In vivo and in vitro models of the human colonic flora. Critical Reviews Food Science and Nutrition. 31, 299-331.
46. Rumney, C.J. & Rowland, I.R. (1995) Microbiological endpoint testing for veterinary antimicrobials setting MRLs. Food and Chemical Toxicology. 33, 331-333.
47. Silley, P. & Watson, P. (1998) A Simple in vitro Gut Simulation Model for Assessing Survival of Campylobacter spp. 98th General Meeting American Society for Microbiology (Abstracts), p. 121.
48. Thompson, S.R. (1999) Chemical food borne hazards and their control. International harmonization issues. The Veterinary Clinics of North America Food Animal Practice. 15, 181-195.
49. US FDA CVM (1994) Guideline for Establishing a Withdrawal Period. In General Principles for Evaluating the Safety of Compounds Used in Food-producing Animals. Guideline VI: Part A. US Food and Drug Administration of Department of Health and Health Human Services.
50. US FDA CVM (1996) Guidance 52: Microbiological Testing of Antimicrobial Drug Residues in Food. FDA. Rockville. MD. USA.
51. US FDA CVM (2003) Evaluating the Safety of Antimicrobial New Animal Drugs with Regard to Their Microbiological Effects on Bacteria of Human Health Concern. Guidance for Industry No. 152. Available at: http://www.fda.gov/cvm/ guidance/published.htm.
52. US FDA CVM (2004) Assessment of the Effects of Antimicrobial Drug Residues from Food of Animal Origin on the Human Intestinal Flora. Guidance Document No. 52. Available at: http://www.fda.gov/cvm/guidance/published.htm.
53. VICH (2003) Pre-approval Information for Registration of New Veterinary Medicinal Products for Food Producing Animals with Respect to Antimicrobial Resistance. Guideline No. 27 for implementation on 15 December 2004.
54. VICH (2004) Studies to Evaluate the Safety of Residues of Veterinary Drugs in Human Food: General Approach to Establish a Microbiological ADI VICH Guideline No. 36 (Safety: General Approach) May 2004 for implementation by May 2005.
55. Vollaard, E.J. & Clasener, H.A.L. (1994) Colonization resistance. Anti-microbial Agents and Chemotherapy, 38, 409-414.
56. Woodward, K.N. (1998) The use of microbiological end-points in the safety evaluation and elaboration of maximum residue limits for veterinary drugs intended for use in food producing animals. Journal of Veterinary Pharmacology and Therapeutics. 21, 47-53.